Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
NCT04959201

Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia

Led by China Medical University Hospital · Updated on 2025-02-19

90

Participants Needed

1

Research Sites

326 weeks

Total Duration

On this page

Sponsors

C

China Medical University Hospital

Lead Sponsor

M

Ministry of Science and Technology, Taiwan

Collaborating Sponsor

AI-Summary

What this Trial Is About

Previous studies found that some NMDA-enhancing agents were able to improve clinical symptoms of patients with schizophrenia. In addition, several drugs with antioxidant properties have been tested in clinical trials for the treatment of schizophrenia too. Whether combined treatment of an NMDA-enhancing agent and a drug with antioxidant property can be better than an NMDA-enhancing agent alone deserves study.

CONDITIONS

Official Title

Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have a DSM-5 diagnosis of schizophrenia
  • Remain symptomatic without clinically significant fluctuation
  • Antipsychotic doses unchanged for at least 3 months and maintained during the 12-week trial
  • PANSS total score 60
  • Agree to participate and provide informed consent
Not Eligible

You will not qualify if you...

  • Diagnosis of intellectual disability or substance (including alcohol) use disorder
  • History of epilepsy, head trauma, stroke, or serious medical or central nervous system diseases other than schizophrenia
  • Clinically significant abnormal laboratory screening tests
  • Pregnancy or lactation
  • Inability to follow the study protocol

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Psychiatry, China Medical University Hospital

Taichung, Taiwan

Actively Recruiting

Loading map...

Research Team

H

Hsien-Yuan Lane, M.D., Ph.D

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here